These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18055024)

  • 21. Identification of therapeutic drug targets through genetically manipulated mice: are we getting it right?
    Matthaei KI
    Pharmacol Ther; 2009 Jul; 123(1):32-6. PubMed ID: 19375454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moving toward individualized cancer therapies.
    Tonon G; Anderson KC
    Clin Cancer Res; 2008 Aug; 14(15):4682-4. PubMed ID: 18676734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine.
    Foekens JA; Wang Y; Martens JW; Berns EM; Klijn JG
    Drug Discov Today; 2008 Jun; 13(11-12):481-7. PubMed ID: 18549973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
    Glinsky GV
    J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The integration of personalized and systems medicine: bioinformatics support for pharmacogenomics and drug discovery.
    Yan Q
    Methods Mol Biol; 2008; 448():1-19. PubMed ID: 18370227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of information flow-modulating drug targets: a novel bridging paradigm for drug discovery.
    Hwang WC; Zhang A; Ramanathan M
    Clin Pharmacol Ther; 2008 Nov; 84(5):563-72. PubMed ID: 18615007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel genomic methods for drug discovery and mechanism-based toxicological assessment.
    Gant TW; Zhang SD; Taylor EL
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):72-80. PubMed ID: 19152215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seed-based systematic discovery of specific transcription factor target genes.
    Mrowka R; Blüthgen N; Fähling M
    FEBS J; 2008 Jun; 275(12):3178-92. PubMed ID: 18485006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applications of genomic tools to colorectal cancer therapeutics.
    Auman JT; McLeod HL
    Curr Opin Mol Ther; 2008 Dec; 10(6):548-54. PubMed ID: 19051132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How will genetic approaches assist in the management of respiratory diseases?
    Hall IP
    Curr Opin Pharmacol; 2009 Jun; 9(3):256-61. PubMed ID: 19409845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection and interpretation of expression quantitative trait loci (eQTL).
    Michaelson JJ; Loguercio S; Beyer A
    Methods; 2009 Jul; 48(3):265-76. PubMed ID: 19303049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Potential role of microRNAs in human diseases and the exploration on design of small molecule agents].
    Zhang Y; Lu YJ; Yang BF
    Yao Xue Xue Bao; 2007 Nov; 42(11):1115-21. PubMed ID: 18300464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia.
    Baldus CD; Bullinger L
    Semin Oncol; 2008 Aug; 35(4):356-64. PubMed ID: 18692686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression-driven reverse engineering of targeted imaging and therapeutic agents.
    Gillies RJ; Hruby VJ
    Expert Opin Ther Targets; 2003 Apr; 7(2):137-9. PubMed ID: 12667092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression analysis as an aid to the identification of drug targets.
    Zanders ED
    Pharmacogenomics; 2000 Nov; 1(4):375-84. PubMed ID: 11257923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translational medicine: the discovery of bridging biomarkers using pharmacogenomics.
    Mendrick DL
    Pharmacogenomics; 2006 Sep; 7(6):943-7. PubMed ID: 16981852
    [No Abstract]   [Full Text] [Related]  

  • 37. A survey on the computational approaches to identify drug targets in the postgenomic era.
    Dai YF; Zhao XM
    Biomed Res Int; 2015; 2015():239654. PubMed ID: 26060814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss-of-function genetic diseases and the concept of pharmaceutical targets.
    Ségalat L
    Orphanet J Rare Dis; 2007; 2():30. PubMed ID: 17674486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Target practice: oncology drug development in the era of genomic medicine.
    Schilsky RL
    Clin Trials; 2007; 4(2):163-6; discussion 173-7. PubMed ID: 17456516
    [No Abstract]   [Full Text] [Related]  

  • 40. Single cell expression analysis--pharmacogenomic potential.
    Dixon AK; Lee K; Richardson PJ; Bell MI; Skynner MJ
    Pharmacogenomics; 2002 Nov; 3(6):809-22. PubMed ID: 12437482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.